Troponin I, Cardiac, Mab MoxBo

The University of Nebraska Board of Regents awarded a purchase order (PO #4800178206) to United States Biological Corp, located in Salem, Massachusetts, on February 10, 2026. The contract value totals $827 and covers the procurement of one unit of Troponin I, Cardiac, Monoclonal Antibody MoxBo (material number T8665-13F-PE), a cardiac biomarker reagent. The goods are to be delivered to the University of Nebraska Medical Center Shipping and Receiving department in Omaha, Nebraska by February 19, 2026, under a free-on-board destination freight-prepaid shipping arrangement.

Performance under this purchase order is scheduled for completion within nine days of award, with the vendor required to acknowledge acceptance within ten days of the order date. Payment terms are Net 30, with the University of Nebraska Board of Regents providing payment via Nebraska State Treasury warrants. The purchase order is tax-exempt under the University's federal tax-exempt status (#05-8905401), and the vendor must reference the purchase order number on all packages, invoices, and supporting documentation.